首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
医学
British scientists are preparing to launch trials of a radical new way to fight cancer, which kills tumours by infecting them wi
British scientists are preparing to launch trials of a radical new way to fight cancer, which kills tumours by infecting them wi
admin
2013-12-14
6
问题
British scientists are preparing to launch trials of a radical new way to fight cancer, which kills tumours by infecting them with viruses like the common cold.
If successful, virus therapy could eventually form a third pillar alongside radiotherapy and chemotherapy in the standard arsenal against cancer, while avoiding some of the debilitating side-effects.
Leonard Seymour, a professor of gene therapy at Oxford University, who has been working on the virus therapy with colleagues in London and the US, will lead the trials later this year. Cancer Research UK said yesterday that it was excited by the potential of Prof. Seymour’s pioneering techniques.
One of the country’s leading geneticists, Prof. Seymour has been working with viruses that kill cancer cells directly, while avoiding harm to healthy tissue. "In principle, you’ve got something which could be many times more effective than regular chemotherapy," he said.
Cancer-killing viruses exploit the fact that cancer cells suppress the body’s local immune system. "If a cancer doesn’t do that, the immune system wipes it out. If you can get a virus into a tumour, viruses find them a very good place to be because there’s no immune system to stop them replicating. You can regard it as the cancer’s Achilles’ heel."
Only a small amount of the virus needs to get to the cancer. "They replicate, you get a million copies in each cell and the cell bursts and they infect the tumour cells adjacent and repeat the process," said Prof. Seymour.
Preliminary research on mice shows that the viruses work well on tumours resistant to standard cancer drugs. "It’s an interesting possibility that they may have an advantage in killing drug-resistant tumours, which could be quite different to anything we’ve had before."
Researchers have known for some time that viruses can kill tumour cells and some aspects of the work have already been published in scientific journals. American scientists have previously injected viruses directly into tumours but this technique will not work if the cancer is inaccessible or has spread throughout the body.
Prof. Seymour’s innovative solution is to mask the virus from the body’s immune system, effectively allowing the viruses to do what chemotherapy drugs do — spread through the blood and reach tumours wherever they are. The big hurdle has always been to find a way to deliver viruses to tumours via the bloodstream without the body’s immune system destroying them on the way.
"What we’ve done is make chemical modifications to the virus to put a polymer coat around it - it’s a stealth virus when you inject it," he said.
After the stealth virus infects the tumour, it replicates, but the copies do not have the chemical modifications. If they escape from the tumour, the copies will be quickly recognised and mopped up by the body’s immune system.
The therapy would be especially useful for secondary cancers, called metastases, which sometimes spread around the body after the first tumour appears. "There’s an awful statistic of patients in the west... with malignant cancers; 75% of them go on to die from metastases," said Prof. Seymour.
Two viruses are likely to be examined in the first clinical trials: adenovirus, which normally causes a cold-like illness, and vaccinia, which causes cowpox and is also used in the vaccine against smallpox. For safety reasons, both will be disabled to make them less pathogenic in the trial, but Prof. Seymour said he eventually hopes to use natural viruses.
The first trials will use uncoated adenovirus and vaccinia and will be delivered locally to liver tumours, in order to establish whether the treatment is safe in humans and what dose of virus will be needed. Several more years of trials will be needed, eventually also on the polymer-coated viruses, before the therapy can be considered for use in the NHS. Though the approach will be examined at first for cancers that do not respond to conventional treatments, Prof. Seymour hopes that one day it might be applied to all cancers.
To treat tumors spreading out in body, researchers try to______.
选项
A、change the body’ immune system
B、inject chemotherapy drugs into bloodstream
C、increase the amount of injection
D、disguise the viruses on the way to tumors
答案
D
解析
词汇题。见第9段第1句:Prof.Seymour’s innovative solution is to mask the virus from the body’simmune system....(西摩教授创新的解决办法是掩饰病毒让人体的免疫系统识别不出来……)。“mask”的意思是“掩盖,隐蔽,伪装”,在这里和“disguise”同义。
转载请注明原文地址:https://kaotiyun.com/show/X4U3777K
本试题收录于:
医学博士外语题库考研分类
0
医学博士外语
考研
相关试题推荐
Thebestexerciseshouldrequirecontinuous______,ratherthanfrequentstopsandstarts.
Twoequallybrilliantscientistsapplyforaprestigiousresearchfellowshipawardedbyatopscientificorganization.Oneiswh
Readingabookandlisteningtomusicsimultaneouslyseemstobenoproblemforthem.
TheAmericanresearchuniversityisaremarkableinstitution,longasourceofadmirationandwonder.Theidyllic(田园诗的),wooded
A、AnEgyptian.B、AnancientRoman.C、Abricklayer.D、Anarchitect.C从“anEnglishbricklayerdevelopedacement”可知。
A、Hewaswithapatient.B、Hewasawayonvacation.C、Hewastalkingtohissecretary.D、Hewasoperating.A女助手说医生刚刚完成一个病人的手术。要稍
A、Inadoctor’soffice.B、Inanoperatingroom.C、Inaprofessor’soffice.D、Inagymnasium.A从“Pleasehaveaseat.Sheisinsur
ProfessorJohnson’sretirement______fromnextJanuary.
RodmanmetwithTonytotryandsettlethedisputeoverhiscontract.
RodmanmetwithTonytotryandsettlethedisputeoverhiscontract.
随机试题
下列成分输血制品中,属于血细胞成分的制品是()
变态反应的含义是()。
患儿男,10个月,生后一直奶粉喂养,未加辅食,体检:营养差,皮肤、黏膜苍白,化验:血红蛋白60g/L,红细胞2.0×1012/L,此患儿确诊为营养性缺铁性贫血,导致该患儿缺铁的主要原因是()
下列各种结构中,不是沉积岩的结构的是()。
某实行监理的工程,实施过程中发生下列事件。事件一:建设单位于2014年11月底向中标的监理单位发出监理中标通知书,监理中标价为280万元;建设单位与监理单位协商后,于2015年1月10目签订了委托监理合同。监理合同约定:合同价为260万元;因非监
建筑工程安全生产管理必须坚持()的方针,建立健全安全生产的责任制度和群防群治制度。
下列对生命周期各个阶段的特征陈述有误的一项是( )。
下列各句中,没有语病的一句是()。
“太学”这一官办教育机构是在哪个朝代出现的?()
[*]
最新回复
(
0
)